Background: A proportion of patients who sustain upper limb fractures develop post-traumatic stiffness (PTS), which may progress in a similar way to primary frozen shoulder (PFS). We have had success in treating PFS with manipulation under anaesthetic (MUA) and therefore treated PTS using MUA. Oxford Shoulder Scores (OSS), range of motion (ROM) data pre-and post-MUA, and the need for repeat procedure were compared. Methods: Sixty-four patients with PTS following an upper limb fracture, unresponsive to conservative measures, were seen between 1 January 1999 and 1 November 2015. Thirty-two patients had sustained a proximal humeral fracture, six of whom had a concurrent shoulder dislocation. MUA was performed using a standard technique. The results were compared with 487 PFS patients undergoing the same procedure.
Introduction
Frozen shoulder (FS), or adhesive capsulitis, manifests as a gradual onset of pain in the shoulder, with a restriction of both active and passive movements, especially external rotation and elevation. This pattern of symptoms was described in 1934 by Codman, 1 and, subsequently, its aetiology, pathology and management have been extensively investigated, although it still remains a relatively poorly understood condition. FS may be classified as primary (idiopathic) or secondary, with the latter being related to injury or other diagnosis (e.g. diabetes mellitus) 2 and it can cause significant debilitation, such that not all cases progress to a spontaneous resolution. 3 Fractures of the upper limb are common, with proximal humerus fractures accounting for 4% to 5% of all fractures, 4 with an unknown but significant proportion of patients going on to develop post-traumatic stiffness (PTS). In the majority of cases, this may be managed with early mobilisation; however, some patients will develop an intractable stiffness, which may progress in a similar way to a primary FS (PFS). What is unknown is whether this PTS represents a similar pathology and natural history to PFS, or whether it is a completely different entity.
There is a consensus that FS follows a pattern consisting of three phases; the first, painful phase is otherwise known as the 'freezing phase'. There is a gradual onset of insidious shoulder pain, with a concurrent decrease in range of motion (ROM). This is followed by a stiff or 'frozen' phase, during which active and passive ROM, especially in the external rotation and elevation planes, is lost. Pain may reduce during this stage. Finally, there is the resolution, or 'thawing' stage, where ROM gradually improves to normal, or near normal levels. 5 Manipulation under anaesthetic (MUA) of PFS has been shown to provide good clinical outcomes, 6, 7 with a small number of complications. 8 It is generally accepted as a reasonable management option. Our group has previously published results for MUA of FS in diabetics and for post-shoulder dislocation stiffness, which demonstrated similar functional outcomes compared to PFS patients. 6, 9 The present retrospective review of a large cohort of prospectively collected patients data outlines the association of PTS with various upper limb trauma fractures (excluding simple shoulder dislocations reported previously), 9 as well as their outcomes, compared to PFS, following MUA.
Materials and Methods
Between 1 January 1999 and 1 November 2015, data on consecutive patients presenting with PTS following an upper limb fracture, or PFS, to a single surgeon (DAW) at a single centre were collected.
The patients all had plain radiographs of their shoulder confirming union of their fracture (if humerus or clavicle) and, in the case of the humeral fractures, no bony cause for their restriction was found. In the PFS cases, the radiographs were normal, excluding osteoarthritis as a cause for their restriction in range of motion. An identical protocol was followed for each patient by the surgeon (DAW); once the FS had been identified, and determined to be in the 'frozen' phase, MUA was advised. Patients were added to the next available operating list. Exclusion criteria included: (i) patients who were not fit for general anaesthetic and (ii) patients who declined MUA. The majority of these patients had previously been managed with a combination of oral analgesia, cortisone injections and variable length of physiotherapy, although they remained with a reduced range of motion of the shoulder and or pain, which was unacceptable to the patient.
The standard protocol for each patient was followed. Patients completed an Oxford Shoulder Score (OSS) prior to the procedure. A general anaesthetic was administered with the patient in a supine position. Pre-manipulation ROM was assessed and recorded. Internal rotation was assessed with the shoulder in neutral adducted position, the elbow flexed to 90 (with the patient supine, the wrist is vertically above the elbow; by internally rotating the shoulder, the angle of the forearm can be measured from the vertical).
MUA was then performed; holding the patient's arm between the shoulder and elbow, the shoulder was initially moved into abduction, followed by flexion, external rotation, cross-body adduction and internal rotation. MUA was repeated until it was considered that the maximum ROM had been achieved, which was then documented. Next 10 mL of 0.5% bupivacaine and 80 mg of Depo-Medrone (Pharmacia Ltd, Sandwich, UK) was then injected anteriorly into the glenohumeral joint before general anaesthetic was ceased.
A standard postoperative physiotherapy regimen was offered to each patient, involving passive and active exercises, as well as hydrotherapy rehabilitation. Reassessment was then performed by the lead surgeon in an outpatient setting, at a mean of 24 days post-MUA, when OSS was recorded. If, at this stage, the patient was not satisfied with their ROM or pain levels, they were monitored for a variable period, as determined by the wishes of the patient. Those who did not have satisfactory relief of symptoms were offered a further MUA (mean interval of 17 weeks).
Statistical analysis was performed using Prism, version 6 (GraphPad, La Jolla, CA, USA). The data were first analysed for normality (D'Agostino-Pearson and S Lancaster et al.
Shapiro-Wilk tests) and, in the main, were found not to be normally distributed. A Mann-Whitney U-test was therefore used to analyse the data, apart from the few occasions when it was normally distributed, in which case a two-tailed t-test was used. p < 0.05 was considered statistically significant. Ethical approval was obtained from the medical advisory committee of the institution.
Results
In total, 67 patients with PTS following an upper limb fracture underwent MUA, two of whom were excluded as a result of loss to follow-up. One patient had undergone a shoulder hemiarthroplasty for fracture and, given that this changed the biology of the shoulder completely, this patient was also excluded, leaving 64 patients with complete data (Group A). A total of 502 patients were identified as having PFS, of whom complete data were available for 487; this group therefore comprised the control group (Group B). The mean age was 51.7 years.
The mean age at first MUA in Group A was 50.8 years. Thirty-nine patients were female and 41 patients presented with left-sided symptoms. There were no bilateral cases. Four patients had diabetes mellitus, two of whom were insulin-dependent. Patients who had developed PTS received a manipulation no sooner than 6 months after their fracture, once radiological union had been confirmed and conservative measures to relieve the stiffness had been attempted. Table 1 outlines the upper limb trauma index injury for patients in Group A. Of the 64 patients, 11 underwent a surgical intervention as part of their fracture management. Surgical fixation comprised of either open reduction with internal fixation (ORIF), or intramedullary fixation.
For the ROM results, there was no significant difference in the pre-and post-MUA ROM between the two groups. The only exception was post-MUA internal rotation, where the difference represents less than 10 , which may not be clinically significant (Table 2 ). Significant differences (p < 0.001) in OSS were observed for both the PTS and PFS groups pre-and post-MUA, (Table 3) .
Subgroup analysis was performed for those patients who received a surgical intervention. No significant difference was observed in OSS or ROM data when comparing those who had undergone surgery with those who received non-operative management.
Discussion
Previous series have outlined the complication of FS following surgery for proximal humerus fractures. In 2010, Clavert et al. 10 found that 4.1% (three of 73 patients) who had undergone ORIF for fractured proximal humerus developed PTS. Their patients were managed using an arthroscopic release; however, further follow-up was not reported.
Horneff and Namdari, 11 in their instructional article on postoperative shoulder stiffness, emphasise the importance of distinguishing postoperative stiffness as a result of a bony or anatomical cause from that of FS. They advocate the use of arthroscopic capsular release rather than MUA because of concerns over refracture, and release was performed at 6 months to 9 months following ORIF. Horneff and Namdari 11 did not report any clinical results with which we could compare our outcomes.
Although shoulder stiffness following upper limb fracture is a well-recognised complication, the incidence of PTS is unknown. Reviewing the literature provides little in the way of prevalence and management of these patients. The only similar study by Wang et al. 12 compared the results of short-and long-term outcomes following FS MUA for idiopathic (primary), postoperative and post-injury FS. Wang et al. 12 utilised the Constant Shoulder Score, investigating 47 patients (51 shoulders). In all three of their groups, there was a significant improvement in the Constant Shoulder Score, from a pre-operative median of 22.8 to 52.6 postoperatively. This score was generally maintained for the longer-term follow-up of 82 months. The postsurgery group did produce lower scores in terms of pain and ROM data compared to the primary FS and posttrauma groups, although the total Constant Shoulder Score was still comparable to the other two groups.
The pathological findings of FS tissue have demonstrated chronic inflammatory changes, with active fibroblastic proliferation. 13, 14 Increased nerve and vascular tissue is also a feature 13 and primary FS is often characterised as contracture of the glenohumeral capsule, the coracohumeral ligament and subscapularis, as well as as excessive type III collagen secretion, resulting in contracture of the subacromial bursa. 14 The pathology of PTS is poorly understood, although it is considered that increased contraction of the rotator cuff is the main cause. This theory was supported by Levy et al. 15 who performed arthroscopic capsular release on 21 patients presenting with post-traumatic shoulder stiffness. They described soft tissue adhesions and contracture as the overwhelming operative findings.
We did not encounter any significant complications in this group, other than the need for repeat MUA in a small proportion of patients. However, it is accepted that fracture may be a complication of MUA. 8 We therefore would not advocate the use of MUA in patients who clearly have osteoporosis, or evidence of an un-united fracture.
We acknowledge the limitations of this retrospective single surgeon cohort study. There will be some patients who were not included because, instead, they would have been discharged from a fracture clinic, regardless of whether they were fit or unwilling to undergo MUA. Some patients will not have re-presented, accepting that a post-injury decreased ROM may be 'part and parcel' of having sustained a fracture, and that this would be a normal post-injury course. The incidence of PTS following trauma is therefore likely to be higher than in this series. Furthermore, we appreciate that the significant differences that were observed were related to OSS, rather than objective change in ROM; an improvement in OSS could be attributed to possible placebo effect; however, we feel the OSS reflects genuine improvement in subjective symptoms in these patients.
The mean age of patients at first MUA was 50.8 years. Comparatively, this may be considered to be much younger than the usual population in whom a proximal humeral fracture is seen. This is therefore a young patient cohort, although it does include fractures with a younger age of presentation (e.g. clavicle fractures). We have not included rotator cuff injuries in this group, choosing instead to focus on bony trauma, although this group also has an incidence of PTS.
Despite our short follow-up time, we have previously presented work showing that OSS is maintained in the longer term for patients following MUA. 7, 16 We have also shown that patients usually respond to MUA within a very short time frame, usually within a few days, and certainly within 3 weeks, such that, if no or minimal improvement is shown at followup, then further progress is unlikely. However, we attempt further non-operative treatment in these patients unless (or until) they make no further progress and therefore the offer of a repeat MUA at this stage is justified.
Conclusions
The present study has shown that MUA does give measurable improvement for patients presenting with PTS that has failed other non-operative measures. The ROM data demonstrated no significant difference between the PTS and PFS groups, although the change in OSS did appear to be significantly higher (17 versus 14) in the PFS group. It is unclear whether PTS represents a different pathological aetiology from PFS, although certainly MUA appears to be an acceptable management option with good functional results and we have experienced no complications using this method.
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